Article metrics

Download PDFPDF

Original research
Efficacy and safety of tofacitinib modified-release 11 mg once daily plus methotrexate in adult patients with rheumatoid arthritis: 24-week open-label phase results from a phase 3b/4 methotrexate withdrawal non-inferiority study (ORAL Shift)

 

Online download statistics by month:

Online download statistics by month: June 2021 to September 2021

AbstractFullPdf
Jun 2021359359165
Jul 202110110049
Aug 2021807629
Sep 2021959251
Total635627294